Drugmaker Novo Nordisk overtakes LVMH as Europe's most valuable company
By Lucy Raitano and Danilo Masoni LONDON (Reuters) -Danish drugmaker Novo Nordisk unseated LVMH as Europe's most valuable listed company
2023-09-02 00:23
Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market
By Ludwig Burger and Maggie Fick FRANKFURT Novo Nordisk has launched blockbuster weight-loss drug Wegovy in Germany, its
2023-07-29 22:48
"Last hope": Eager Germans are prepared to pay for weight-loss drug
By Ludwig Burger and Maggie Fick FRANKFURT/LONDON Frustrated after countless failed diet and exercise attempts, 41 year-old Jessica
2023-07-25 18:53
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
By Maggie Fick LONDON Soaring U.S. demand for Novo Nordisk's weight-loss drug has reduced the pressure from investors
2023-07-14 13:23
EU probes Novo Nordisk drugs after reports of suicidal thoughts
(Reuters) -The European Medicines Agency (EMA) is probing Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health
2023-07-10 21:22
Novo Nordisk says obesity pill leads to 15% weight loss; availability "to be determined"
By Deena Beasley SAN DIEGO Drugmaker Novo Nordisk on Sunday said a late-stage trial found that a high-dose
2023-06-26 09:15
Novo Nordisk invests $2.3 billion in Danish production facility
COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk will invest 15.9 billion Danish crowns ($2.29 billion) to expand a production facility in
2023-06-12 14:20
Novo Nordisk in talks buy controlling stake in Biocorp
Danish drug developer Novo Nordisk said on Monday it had started talks to buy a controlling stake in
2023-06-05 14:21
Novo Nordisk: trial data of oral weight-loss drug comparable to Wegovy
By Louise Rasmussen COPENHAGEN (Reuters) -Novo Nordisk said on Monday data from a late-stage trial showed an oral version of
2023-05-23 00:56